Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
4.270
-0.010 (-0.23%)
Mar 25, 2026, 4:00 PM EDT - Market closed
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $12.19 million as of March 25, 2026. Its market cap has increased by 22.42% in one year.
Market Cap
12.19M
Enterprise Value
4.63M
1-Year Change
22.42%
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $12.19M, a decrease of -78.70%. That is a compound annual growth rate of -27.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 12.19M | 108.51% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 13.29M |
| BioCardia | 13.13M |
| Kairos Pharma | 12.54M |
| Cellectar Biosciences | 12.51M |
| CytoMed Therapeutics | 12.23M |
| Soligenix | 12.10M |
| Jupiter Neurosciences | 12.07M |
| Chemomab Therapeutics | 11.44M |